Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) market report explains the definition, types, applications, major countries, and major players of the Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.
The report contains qualitative and quantitative analysis of the entire industry.
The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.
By Player:
Spectrum
Shire
Novadiol
Abbott
Akebia
Daiichi-Sankyo
Abbvie
Shield
Astellas
OPKO
Amgen
Ardelyx
Sanofi Genzyme
Vifor
Japan Tobacco Company
Fresenius
By Type:
Control Hyperphosphatemia
Maintain Blood Calcium Levels
Control PTH Level
Correct Acidosis
Other
By End-User:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Drug Stores
Other
By Region:
North America
-
United States
-
Canada
-
Mexico
Europe
-
Germany
-
UK
-
Spain
-
France
-
Italy
-
Denmark
-
Finland
-
Norway
-
Sweden
-
Poland
-
Russia
-
Turkey
Asia-Pacific
-
China
-
Japan
-
India
-
South Korea
-
Pakistan
-
Bangladesh
-
Indonesia
-
Thailand
-
Singapore
-
Malaysia
-
Philippines
-
Vietnam
-
Others
South America
-
Brazil
-
Colombia
-
Chile
-
Argentina
-
Venezuela
-
Peru
-
Puerto Rico
-
Ecuador
-
Others
GCC
-
Bahrain
-
Kuwait
-
Oman
-
Qatar
-
Saudi Arabia
-
United Arab Emirates
Africa
-
Nigeria
-
South Africa
-
Egypt
-
Algeriat
-
Others
Oceania
-
Australia
-
New Zealand
TABLE OF CONTENT
1. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Executive Summary
-
1.1 Introduction
-
1.2 Market Panorama, 2022
2 Coronavirus Impact
-
2.1 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Outlook to 2028- Original Forecasts
-
2.2 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Outlook to 2028- COVID-19 Affected Forecasts
-
2.3 Impact on Industry
3 Strategic Analytics to Boost Productivity and Profitability
-
3.1 Potential Market Drivers and Opportunities
-
3.2 New Challenges and Strategies
-
3.3 Short Term and Long Term Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Trends
4 Key Inferences
5 Market Overview
-
5.1 Current Market Scenario
-
5.2 Porter's Five Forces Analysis
-
5.2.1 Bargaining Power of Suppliers
-
5.2.2 Bargaining Power of Consumers
-
5.2.3 Threat of New Entrants
-
5.2.4 Threat of Substitute Product and Services
-
5.2.5 Competitive Rivalry within the Industry
6 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market- Recent Developments
-
6.1 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market News and Developments
-
6.2 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Deals Landscape
7 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Raw Materials and Cost Structure Analysis
-
7.1 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Key Raw Materials
-
7.2 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Price Trend of Key Raw Materials
-
7.3 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Key Suppliers of Raw Materials
-
7.4 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Concentration Rate of Raw Materials
-
7.5 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Cost Structure Analysis
-
7.5.1 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Raw Materials Analysis
-
7.5.2 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Labor Cost Analysis
-
7.5.3 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Manufacturing Expenses Analysis
8 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Import and Export Analysis (Top 10 Countries)
-
8.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Import by Region (Top 10 Countries) (2017-2028)
-
8.2 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Export by Region (Top 10 Countries) (2017-2028)
9 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Outlook by Types and Applications to 2022
-
9.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Control Hyperphosphatemia Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Maintain Blood Calcium Levels Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Control PTH Level Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Correct Acidosis Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Other Consumption and Growth Rate (2017-2022)
-
9.2 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospital Pharmacies Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Retail Pharmacies Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Online Pharmacies Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Drug Stores Consumption and Growth Rate (2017-2022)
-
9.2.5 Global Other Consumption and Growth Rate (2017-2022)
10 Region and Country-wise Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Analysis and Outlook till 2022
-
10.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption (2017-2022)
-
10.2 North America Consumption Analysis
-
10.2.1 United States Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption (2017-2022)
-
10.2.2 Canada Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption (2017-2022)
-
10.2.3 Mexico Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption (2017-2022)
-
10.3 Europe Consumption Analysis
-
10.3.1 Germany Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption (2017-2022)
-
10.3.2 UK Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption (2017-2022)
-
10.3.3 Spain Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption (2017-2022)
-
10.3.4 Belgium Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption (2017-2022)
-
10.3.5 France Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption (2017-2022)
-
10.3.6 Italy Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption (2017-2022)
-
10.3.7 Denmark Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption (2017-2022)
-
10.3.8 Finland Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption (2017-2022)
-
10.3.9 Norway Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption (2017-2022)
-
10.3.10 Sweden Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption (2017-2022)
-
10.3.11 Poland Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption (2017-2022)
-
10.3.12 Russia Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption (2017-2022)
-
10.3.13 Turkey Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption (2017-2022)
-
10.4 APAC Consumption Analysis
-
10.4.1 China Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption (2017-2022)
-
10.4.2 Japan Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption (2017-2022)
-
10.4.3 India Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption (2017-2022)
-
10.4.4 South Korea Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption (2017-2022)
-
10.4.5 Pakistan Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption (2017-2022)
-
10.4.6 Bangladesh Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption (2017-2022)
-
10.4.7 Indonesia Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption (2017-2022)
-
10.4.8 Thailand Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption (2017-2022)
-
10.4.9 Singapore Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption (2017-2022)
-
10.4.10 Malaysia Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption (2017-2022)
-
10.4.11 Philippines Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption (2017-2022)
-
10.4.12 Vietnam Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption (2017-2022)
-
10.5 South America Consumption Analysis
-
10.5.1 Brazil Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption (2017-2022)
-
10.5.2 Colombia Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption (2017-2022)
-
10.5.3 Chile Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption (2017-2022)
-
10.5.4 Argentina Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption (2017-2022)
-
10.5.5 Venezuela Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption (2017-2022)
-
10.5.6 Peru Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption (2017-2022)
-
10.5.7 Puerto Rico Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption (2017-2022)
-
10.5.8 Ecuador Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption (2017-2022)
-
10.6 GCC Consumption Analysis
-
10.6.1 Bahrain Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption (2017-2022)
-
10.6.2 Kuwait Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption (2017-2022)
-
10.6.3 Oman Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption (2017-2022)
-
10.6.4 Qatar Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption (2017-2022)
-
10.6.5 Saudi Arabia Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption (2017-2022)
-
10.6.6 United Arab Emirates Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption (2017-2022)
-
10.7 Africa Consumption Analysis
-
10.7.1 Nigeria Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption (2017-2022)
-
10.7.2 South Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption (2017-2022)
-
10.7.3 Egypt Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption (2017-2022)
-
10.7.4 Algeria Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption (2017-2022)
-
10.8 Oceania Consumption Analysis
-
10.8.1 Australia Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption (2017-2022)
-
10.8.2 New Zealand Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption (2017-2022)
11 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Competitive Analysis
-
11.1 Spectrum
-
11.1.1 Spectrum Company Details
-
11.1.2 Spectrum Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Price, Value and Gross Profit (2017-2022)
-
11.1.3 Spectrum Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Main Business and Markets Served
-
11.1.4 Spectrum Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolio
-
11.1.5 Recent Research and Development Strategies
-
11.2 Shire
-
11.2.1 Shire Company Details
-
11.2.2 Shire Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Price, Value and Gross Profit (2017-2022)
-
11.2.3 Shire Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Main Business and Markets Served
-
11.2.4 Shire Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolio
-
11.2.5 Recent Research and Development Strategies
-
11.3 Novadiol
-
11.3.1 Novadiol Company Details
-
11.3.2 Novadiol Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Price, Value and Gross Profit (2017-2022)
-
11.3.3 Novadiol Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Main Business and Markets Served
-
11.3.4 Novadiol Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolio
-
11.3.5 Recent Research and Development Strategies
-
11.4 Abbott
-
11.4.1 Abbott Company Details
-
11.4.2 Abbott Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Price, Value and Gross Profit (2017-2022)
-
11.4.3 Abbott Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Main Business and Markets Served
-
11.4.4 Abbott Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolio
-
11.4.5 Recent Research and Development Strategies
-
11.5 Akebia
-
11.5.1 Akebia Company Details
-
11.5.2 Akebia Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Price, Value and Gross Profit (2017-2022)
-
11.5.3 Akebia Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Main Business and Markets Served
-
11.5.4 Akebia Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolio
-
11.5.5 Recent Research and Development Strategies
-
11.6 Daiichi-Sankyo
-
11.6.1 Daiichi-Sankyo Company Details
-
11.6.2 Daiichi-Sankyo Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Price, Value and Gross Profit (2017-2022)
-
11.6.3 Daiichi-Sankyo Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Main Business and Markets Served
-
11.6.4 Daiichi-Sankyo Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolio
-
11.6.5 Recent Research and Development Strategies
-
11.7 Abbvie
-
11.7.1 Abbvie Company Details
-
11.7.2 Abbvie Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Price, Value and Gross Profit (2017-2022)
-
11.7.3 Abbvie Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Main Business and Markets Served
-
11.7.4 Abbvie Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolio
-
11.7.5 Recent Research and Development Strategies
-
11.8 Shield
-
11.8.1 Shield Company Details
-
11.8.2 Shield Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Price, Value and Gross Profit (2017-2022)
-
11.8.3 Shield Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Main Business and Markets Served
-
11.8.4 Shield Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolio
-
11.8.5 Recent Research and Development Strategies
-
11.9 Astellas
-
11.9.1 Astellas Company Details
-
11.9.2 Astellas Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Price, Value and Gross Profit (2017-2022)
-
11.9.3 Astellas Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Main Business and Markets Served
-
11.9.4 Astellas Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolio
-
11.9.5 Recent Research and Development Strategies
-
11.10 OPKO
-
11.10.1 OPKO Company Details
-
11.10.2 OPKO Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Price, Value and Gross Profit (2017-2022)
-
11.10.3 OPKO Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Main Business and Markets Served
-
11.10.4 OPKO Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolio
-
11.10.5 Recent Research and Development Strategies
-
11.11 Amgen
-
11.11.1 Amgen Company Details
-
11.11.2 Amgen Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Price, Value and Gross Profit (2017-2022)
-
11.11.3 Amgen Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Main Business and Markets Served
-
11.11.4 Amgen Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolio
-
11.11.5 Recent Research and Development Strategies
-
11.12 Ardelyx
-
11.12.1 Ardelyx Company Details
-
11.12.2 Ardelyx Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Price, Value and Gross Profit (2017-2022)
-
11.12.3 Ardelyx Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Main Business and Markets Served
-
11.12.4 Ardelyx Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolio
-
11.12.5 Recent Research and Development Strategies
-
11.13 Sanofi Genzyme
-
11.13.1 Sanofi Genzyme Company Details
-
11.13.2 Sanofi Genzyme Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Price, Value and Gross Profit (2017-2022)
-
11.13.3 Sanofi Genzyme Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Main Business and Markets Served
-
11.13.4 Sanofi Genzyme Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolio
-
11.13.5 Recent Research and Development Strategies
-
11.14 Vifor
-
11.14.1 Vifor Company Details
-
11.14.2 Vifor Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Price, Value and Gross Profit (2017-2022)
-
11.14.3 Vifor Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Main Business and Markets Served
-
11.14.4 Vifor Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolio
-
11.14.5 Recent Research and Development Strategies
-
11.15 Japan Tobacco Company
-
11.15.1 Japan Tobacco Company Company Details
-
11.15.2 Japan Tobacco Company Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Price, Value and Gross Profit (2017-2022)
-
11.15.3 Japan Tobacco Company Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Main Business and Markets Served
-
11.15.4 Japan Tobacco Company Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolio
-
11.15.5 Recent Research and Development Strategies
-
11.16 Fresenius
-
11.16.1 Fresenius Company Details
-
11.16.2 Fresenius Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Price, Value and Gross Profit (2017-2022)
-
11.16.3 Fresenius Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Main Business and Markets Served
-
11.16.4 Fresenius Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolio
-
11.16.5 Recent Research and Development Strategies
12 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Outlook by Types and Applications to 2028
-
12.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption Forecast and Growth Rate by Type (2022-2028)
-
12.1.1 Global Control Hyperphosphatemia Consumption Forecast and Growth Rate (2022-2028)
-
12.1.2 Global Maintain Blood Calcium Levels Consumption Forecast and Growth Rate (2022-2028)
-
12.1.3 Global Control PTH Level Consumption Forecast and Growth Rate (2022-2028)
-
12.1.4 Global Correct Acidosis Consumption Forecast and Growth Rate (2022-2028)
-
12.1.5 Global Other Consumption Forecast and Growth Rate (2022-2028)
-
12.2 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption Forecast and Growth Rate by Application (2022-2028)
-
12.2.1 Global Hospital Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
12.2.2 Global Retail Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
12.2.3 Global Online Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
12.2.4 Global Drug Stores Consumption Forecast and Growth Rate (2022-2028)
-
12.2.5 Global Other Consumption Forecast and Growth Rate (2022-2028)
13 Country-wise Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Analysis and Outlook to 2028
-
13.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption Forecast (2022-2028)
-
13.2 North America Consumption Analysis
-
13.2.1 United States Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption Forecast (2022-2028)
-
13.2.2 Canada Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption Forecast (2022-2028)
-
13.2.3 Mexico Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption Forecast (2022-2028)
-
13.3 Europe Consumption Analysis
-
13.3.1 Germany Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption Forecast (2022-2028)
-
13.3.2 UK Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption Forecast (2022-2028)
-
13.3.3 Spain Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption Forecast (2022-2028)
-
13.3.4 Belgium Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption Forecast (2022-2028)
-
13.3.5 France Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption Forecast (2022-2028)
-
13.3.6 Italy Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption Forecast (2022-2028)
-
13.3.7 Denmark Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption Forecast (2022-2028)
-
13.3.8 Finland Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption Forecast (2022-2028)
-
13.3.9 Norway Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption Forecast (2022-2028)
-
13.3.10 Sweden Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption Forecast (2022-2028)
-
13.3.11 Poland Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption Forecast (2022-2028)
-
13.3.12 Russia Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption Forecast (2022-2028)
-
13.3.13 Turkey Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption Forecast (2022-2028)
-
13.4 APAC Consumption Analysis
-
13.4.1 China Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption Forecast (2022-2028)
-
13.4.2 Japan Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption Forecast (2022-2028)
-
13.4.3 India Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption Forecast (2022-2028)
-
13.4.4 South Korea Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption Forecast (2022-2028)
-
13.4.5 Pakistan Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption Forecast (2022-2028)
-
13.4.6 Bangladesh Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption Forecast (2022-2028)
-
13.4.7 Indonesia Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption Forecast (2022-2028)
-
13.4.8 Thailand Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption Forecast (2022-2028)
-
13.4.9 Singapore Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption Forecast (2022-2028)
-
13.4.10 Malaysia Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption Forecast (2022-2028)
-
13.4.11 Philippines Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption Forecast (2022-2028)
-
13.4.12 Vietnam Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption Forecast (2022-2028)
-
13.5 South America Consumption Analysis
-
13.5.1 Brazil Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption Forecast (2022-2028)
-
13.5.2 Colombia Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption Forecast (2022-2028)
-
13.5.3 Chile Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption Forecast (2022-2028)
-
13.5.4 Argentina Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption Forecast (2022-2028)
-
13.5.5 Venezuela Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption Forecast (2022-2028)
-
13.5.6 Peru Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption Forecast (2022-2028)
-
13.5.7 Puerto Rico Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption Forecast (2022-2028)
-
13.5.8 Ecuador Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption Forecast (2022-2028)
-
13.6 GCC Consumption Analysis
-
13.6.1 Bahrain Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption Forecast (2022-2028)
-
13.6.2 Kuwait Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption Forecast (2022-2028)
-
13.6.3 Oman Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption Forecast (2022-2028)
-
13.6.4 Qatar Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption Forecast (2022-2028)
-
13.6.5 Saudi Arabia Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption Forecast (2022-2028)
-
13.6.6 United Arab Emirates Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption Forecast (2022-2028)
-
13.7 Africa Consumption Analysis
-
13.7.1 Nigeria Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption Forecast (2022-2028)
-
13.7.2 South Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption Forecast (2022-2028)
-
13.7.3 Egypt Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption Forecast (2022-2028)
-
13.7.4 Algeria Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption Forecast (2022-2028)
-
13.8 Oceania Consumption Analysis
-
13.8.1 Australia Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption Forecast (2022-2028)
-
13.8.2 New Zealand Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption Forecast (2022-2028)
14 Conclusions
The List of Tables and Figures
-
Table Definition of Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD)
-
Figure of Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Picture
-
Table Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Import by Region (Top 10 Countries) (2017-2028)
-
Table Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Export by Region (Top 10 Countries) (2017-2028)
-
Figure Global Control Hyperphosphatemia Consumption and Growth Rate (2017-2022)
-
Figure Global Maintain Blood Calcium Levels Consumption and Growth Rate (2017-2022)
-
Figure Global Control PTH Level Consumption and Growth Rate (2017-2022)
-
Figure Global Correct Acidosis Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Pharmacies Consumption and Growth Rate (2017-2022)
-
Figure Global Retail Pharmacies Consumption and Growth Rate (2017-2022)
-
Figure Global Online Pharmacies Consumption and Growth Rate (2017-2022)
-
Figure Global Drug Stores Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption by Country (2017-2022)
-
Table North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption by Country (2017-2022)
-
Figure United States Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption and Growth Rate (2017-2022)
-
Figure Canada Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption and Growth Rate (2017-2022)
-
Figure Mexico Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption and Growth Rate (2017-2022)
-
Table Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption by Country (2017-2022)
-
Figure Germany Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption and Growth Rate (2017-2022)
-
Figure UK Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption and Growth Rate (2017-2022)
-
Figure Spain Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption and Growth Rate (2017-2022)
-
Figure Belgium Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption and Growth Rate (2017-2022)
-
Figure France Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption and Growth Rate (2017-2022)
-
Figure Italy Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption and Growth Rate (2017-2022)
-
Figure Denmark Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption and Growth Rate (2017-2022)
-
Figure Finland Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption and Growth Rate (2017-2022)
-
Figure Norway Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption and Growth Rate (2017-2022)
-
Figure Sweden Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption and Growth Rate (2017-2022)
-
Figure Poland Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption and Growth Rate (2017-2022)
-
Figure Russia Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption and Growth Rate (2017-2022)
-
Figure Turkey Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption and Growth Rate (2017-2022)
-
Table APAC Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption by Country (2017-2022)
-
Figure China Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption and Growth Rate (2017-2022)
-
Figure Japan Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption and Growth Rate (2017-2022)
-
Figure India Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption and Growth Rate (2017-2022)
-
Figure South Korea Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption and Growth Rate (2017-2022)
-
Figure Pakistan Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption and Growth Rate (2017-2022)
-
Figure Bangladesh Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption and Growth Rate (2017-2022)
-
Figure Indonesia Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption and Growth Rate (2017-2022)
-
Figure Thailand Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption and Growth Rate (2017-2022)
-
Figure Singapore Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption and Growth Rate (2017-2022)
-
Figure Malaysia Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption and Growth Rate (2017-2022)
-
Figure Philippines Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption and Growth Rate (2017-2022)
-
Figure Vietnam Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption and Growth Rate (2017-2022)
-
Table South America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption by Country (2017-2022)
-
Figure Brazil Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption and Growth Rate (2017-2022)
-
Figure Colombia Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption and Growth Rate (2017-2022)
-
Figure Chile Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption and Growth Rate (2017-2022)
-
Figure Argentina Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption and Growth Rate (2017-2022)
-
Figure Venezuela Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption and Growth Rate (2017-2022)
-
Figure Peru Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption and Growth Rate (2017-2022)
-
Figure Puerto Rico Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption and Growth Rate (2017-2022)
-
Figure Ecuador Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption and Growth Rate (2017-2022)
-
Table GCC Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption by Country (2017-2022)
-
Figure Bahrain Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption and Growth Rate (2017-2022)
-
Figure Kuwait Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption and Growth Rate (2017-2022)
-
Figure Oman Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption and Growth Rate (2017-2022)
-
Figure Qatar Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption and Growth Rate (2017-2022)
-
Figure Saudi Arabia Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption and Growth Rate (2017-2022)
-
Figure United Arab Emirates Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption and Growth Rate (2017-2022)
-
Table Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption by Country (2017-2022)
-
Figure Nigeria Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption and Growth Rate (2017-2022)
-
Figure South Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption and Growth Rate (2017-2022)
-
Figure Egypt Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption and Growth Rate (2017-2022)
-
Figure Algeria Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption and Growth Rate (2017-2022)
-
Table Oceania Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption by Country (2017-2022)
-
Figure Australia Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption and Growth Rate (2017-2022)
-
Figure New Zealand Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption and Growth Rate (2017-2022)
-
Table Spectrum Company Details
-
Table Spectrum Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Price, Value and Gross Profit (2017-2022)
-
Table Spectrum Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Main Business and Markets Served
-
Table Spectrum Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolio
-
Table Shire Company Details
-
Table Shire Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Price, Value and Gross Profit (2017-2022)
-
Table Shire Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Main Business and Markets Served
-
Table Shire Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolio
-
Table Novadiol Company Details
-
Table Novadiol Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novadiol Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Main Business and Markets Served
-
Table Novadiol Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolio
-
Table Abbott Company Details
-
Table Abbott Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Price, Value and Gross Profit (2017-2022)
-
Table Abbott Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Main Business and Markets Served
-
Table Abbott Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolio
-
Table Akebia Company Details
-
Table Akebia Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Price, Value and Gross Profit (2017-2022)
-
Table Akebia Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Main Business and Markets Served
-
Table Akebia Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolio
-
Table Daiichi-Sankyo Company Details
-
Table Daiichi-Sankyo Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Price, Value and Gross Profit (2017-2022)
-
Table Daiichi-Sankyo Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Main Business and Markets Served
-
Table Daiichi-Sankyo Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolio
-
Table Abbvie Company Details
-
Table Abbvie Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Price, Value and Gross Profit (2017-2022)
-
Table Abbvie Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Main Business and Markets Served
-
Table Abbvie Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolio
-
Table Shield Company Details
-
Table Shield Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Price, Value and Gross Profit (2017-2022)
-
Table Shield Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Main Business and Markets Served
-
Table Shield Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolio
-
Table Astellas Company Details
-
Table Astellas Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Price, Value and Gross Profit (2017-2022)
-
Table Astellas Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Main Business and Markets Served
-
Table Astellas Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolio
-
Table OPKO Company Details
-
Table OPKO Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Price, Value and Gross Profit (2017-2022)
-
Table OPKO Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Main Business and Markets Served
-
Table OPKO Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolio
-
Table Amgen Company Details
-
Table Amgen Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Price, Value and Gross Profit (2017-2022)
-
Table Amgen Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Main Business and Markets Served
-
Table Amgen Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolio
-
Table Ardelyx Company Details
-
Table Ardelyx Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Price, Value and Gross Profit (2017-2022)
-
Table Ardelyx Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Main Business and Markets Served
-
Table Ardelyx Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolio
-
Table Sanofi Genzyme Company Details
-
Table Sanofi Genzyme Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi Genzyme Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Main Business and Markets Served
-
Table Sanofi Genzyme Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolio
-
Table Vifor Company Details
-
Table Vifor Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Price, Value and Gross Profit (2017-2022)
-
Table Vifor Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Main Business and Markets Served
-
Table Vifor Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolio
-
Table Japan Tobacco Company Company Details
-
Table Japan Tobacco Company Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Price, Value and Gross Profit (2017-2022)
-
Table Japan Tobacco Company Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Main Business and Markets Served
-
Table Japan Tobacco Company Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolio
-
Table Fresenius Company Details
-
Table Fresenius Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Price, Value and Gross Profit (2017-2022)
-
Table Fresenius Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Main Business and Markets Served
-
Table Fresenius Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolio
-
Figure Global Control Hyperphosphatemia Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Maintain Blood Calcium Levels Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Control PTH Level Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Correct Acidosis Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Retail Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Online Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Drug Stores Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption Forecast by Country (2022-2028)
-
Table North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption Forecast by Country (2022-2028)
-
Figure United States Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Canada Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Mexico Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption Forecast by Country (2022-2028)
-
Figure Germany Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption Forecast and Growth Rate (2022-2028)
-
Figure UK Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Spain Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Belgium Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption Forecast and Growth Rate (2022-2028)
-
Figure France Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Italy Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Denmark Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Finland Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Norway Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Sweden Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Poland Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Russia Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Turkey Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption Forecast and Growth Rate (2022-2028)
-
Table APAC Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption Forecast by Country (2022-2028)
-
Figure China Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Pakistan Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Bangladesh Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Indonesia Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Thailand Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Singapore Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Malaysia Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Philippines Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Vietnam Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption Forecast and Growth Rate (2022-2028)
-
Table South America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption Forecast by Country (2022-2028)
-
Figure Brazil Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Colombia Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Chile Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Argentina Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Venezuela Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Peru Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Puerto Rico Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Ecuador Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption Forecast and Growth Rate (2022-2028)
-
Table GCC Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption Forecast by Country (2022-2028)
-
Figure Bahrain Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Kuwait Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Oman Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Qatar Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Saudi Arabia Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption Forecast and Growth Rate (2022-2028)
-
Figure United Arab Emirates Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption Forecast and Growth Rate (2022-2028)
-
Table Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption Forecast by Country (2022-2028)
-
Figure Nigeria Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Egypt Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Algeria Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption Forecast and Growth Rate (2022-2028)
-
Table Oceania Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption Forecast by Country (2022-2028)
-
Figure Australia Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption Forecast and Growth Rate (2022-2028)
-
Figure New Zealand Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption Forecast and Growth Rate (2022-2028)
-
